EMCDDA Home
  • EN
Search

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2010 or most recent year available

Part (vii) New cocaine (HCI and ‘crack’) inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium1::33.366.760
Bulgaria::::00
Czech Republic33.333.333.3:31
Denmark:25.0:75.040
Germany10.733.342.713.3750
Estonia::::::
Ireland52.47.925.414.3639
Greece12.229.326.831.7410
Spain::::::
France:::100.030
Italy::::::
Cyprus66.7::33.330
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary::::00
Malta::::::
Netherlands17.910.427.444.310647
Austria71.03.212.912.9310
Poland2::66.733.331
Portugal::::::
Romania14.328.614.342.974
Slovenia::::::
Slovakia:25.050.025.040
Finland100:::10
Sweden30.44.352.213.0230
Uk3::::::
Croatia25.025.0:50.046
Turkey7.4:29.663.0270
Norway::::::
Total25.315.129.729.940468
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012